Controversial editor and patient safety expert had undisclosed COIs in 9 of 10 papers

A new editorial in the Journal of Patient Safety accuses former editor and patient safety expert Charles Denham of having undeclared conflicts of interest in nine out of ten articles he published in the journal. Denham was at the center of massive controversy earlier this year, when the government accused him of taking more than $11 million in … Continue reading Controversial editor and patient safety expert had undisclosed COIs in 9 of 10 papers

Weekend reads: Novartis fires scientist for faking data; journal accepts F-bomb-laden spam paper

The week at Retraction Watch began with a case of a South Korean engineer who had to retract ten studies at once. Here’s what was happening elsewhere, along with an update on a story we covered a few days ago:

Updated: Former Vanderbilt scientist faked nearly 70 images, will retract 6 papers: ORI

A former Vanderbilt University biomedical engineer committed fraud on a massive scale, according to a new Office of Research Integrity (ORI) report. Igor Dzhura is banned from receiving federal funding for three years, and is retracting six papers, which have been cited more than 500 times. Since leaving Vanderbilt, he has worked at SUNY Upstate … Continue reading Updated: Former Vanderbilt scientist faked nearly 70 images, will retract 6 papers: ORI

Leukemia paper retracted for plagiarism — 18 years later

Nearly two decades after a Polish researcher plagiarized the work of a Turkish team, her theft has been exposed and the paper retracted. According to an article in Polish-language paper Gazeta Wyborcza, Jolanta Rzymowska of the Medical University of Lublin was the subject of two disciplinary hearings, the first in February 2014, following the discovery of her plagiarism … Continue reading Leukemia paper retracted for plagiarism — 18 years later

Weekend reads: Speed kills in publishing too; studying blank pages; apologies for the Rosetta Shirt

Highlights at Retraction Watch this week included a case of overly honest referencing and the story of how a medical resident flagged up a pseudoscientific study. Here’s what was happening elsewhere:

Paper on circulating tumor cells taken out of circulation after lab error

A group of researchers at the Guangdong Academy of Medical Sciences in Guangzhou, China have retracted a paper that came out of a clinical trial on transarterial chemoembolization, a targeted kind of chemotherapy. According to the notice, one of the authors mixed up the control samples with the clinical samples, and “could not recall which samples were in the wrong … Continue reading Paper on circulating tumor cells taken out of circulation after lab error

“Know how to recognize pseudoscience:” Reader reveals how fish oil paper came to be retracted

After our post yesterday on a fishy retraction from author Brian Peskin, a reader who alerted the journal to problems got in touch to give us the lowdown. Ian Garber is in the last year of medical residency at the University of British Columbia. Here’s the story he told us via email:

Weekend reads: “Academic science isn’t sexist;” buying your way into university rankings

The week at Retraction Watch began with news of a lawsuit against PubPeer commenters. Here’s what was happening elsewhere:

Boldt’s data were fake in 1996 paper

Update, 4 p.m. EST, 10/29/14: As a commenter points out, we didn’t quite get this one right. The Boldt paper that has been retracted was not previously retracted for lack of IRB approval. Rather, it was a heretofore unretracted article, from 1996, which German investigators have determined contained faked data. We’ve made edits below using … Continue reading Boldt’s data were fake in 1996 paper

Scientist sues PubPeer commenters, subpoenas site for names

Last month, we reported that a Wayne State University cancer researcher had threatened legal action involving post-publication peer review site PubPeer, claiming that he had lost a job offer from the University of Mississippi because of comments on the site. Fazlul Sarkar — who has received $12.8 million in NIH funding and has been an investigator … Continue reading Scientist sues PubPeer commenters, subpoenas site for names